Ignite Creation Date:
2024-05-06 @ 10:07 AM
Last Modification Date:
2024-10-26 @ 12:24 PM
Study NCT ID:
NCT03160885
Status:
COMPLETED
Last Update Posted:
2023-02-24
First Post:
2017-05-18
Brief Title:
Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 ECZema TRAlokinumab Trial no 2
Sponsor:
LEO Pharma
Organization:
LEO Pharma
Organization Data
Organization:
LEO Pharma
Class:
INDUSTRY
Study ID:
LP0162-1326
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
LEO Pharma
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None